Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study

dc.authorscopusid22836913800
dc.authorscopusid7005578733
dc.authorscopusid7102333663
dc.authorscopusid57546402900
dc.authorscopusid26532535300
dc.authorscopusid35298367600
dc.authorscopusid55401193200
dc.contributor.authorTanoglu, A.
dc.contributor.authorErdem, H.
dc.contributor.authorFriedland, J.S.
dc.contributor.authorAnkaralı, H.
dc.contributor.authorGarcia-Goez, J.F.
dc.contributor.authorAlbayrak, A.
dc.contributor.authorEl-Kholy, A.
dc.date.accessioned2024-08-25T18:36:54Z
dc.date.available2024-08-25T18:36:54Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractExisting literature about peritoneal tuberculosis (TBP) is relatively insufficient. The majority of reports are from a single center and do not assess predictive factors for mortality. In this international study, we investigated the clinicopathological characteristics of a large series of patients with TBP and determined the key features associated with mortality. TBP patients detected between 2010 and 2022 in 38 medical centers in 13 countries were included in this retrospective cohort. Participating physicians filled out an online questionnaire to report study data. In this study, 208 patients with TBP were included. Mean age of TBP cases was 41.4 ± 17.5 years. One hundred six patients (50.9%) were females. Nineteen patients (9.1%) had HIV infection, 45 (21.6%) had diabetes mellitus, 30 (14.4%) had chronic renal failure, 12 (5.7%) had cirrhosis, 7 (3.3%) had malignancy, and 21 (10.1%) had a history of immunosuppressive medication use. A total of 34 (16.3%) patients died and death was attributable to TBP in all cases. A pioneer mortality predicting model was established and HIV positivity, cirrhosis, abdominal pain, weakness, nausea and vomiting, ascites, isolation of Mycobacterium tuberculosis in peritoneal biopsy samples, TB relapse, advanced age, high serum creatinine and ALT levels, and decreased duration of isoniazid use were significantly related with mortality (p < 0.05). This is the first international study on TBP and is the largest case series to date. We suggest that using the mortality predicting model will allow early identification of high-risk patients likely to die of TBP. © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.en_US
dc.identifier.doi10.1007/s10096-023-04630-9
dc.identifier.endpage992en_US
dc.identifier.issn0934-9723
dc.identifier.issue8en_US
dc.identifier.pmid37318601en_US
dc.identifier.scopus2-s2.0-85161975258en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage981en_US
dc.identifier.urihttps://doi.org/10.1007/s10096-023-04630-9
dc.identifier.urihttps://hdl.handle.net/11454/100793
dc.identifier.volume42en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Science and Business Media Deutschland GmbHen_US
dc.relation.ispartofEuropean Journal of Clinical Microbiology and Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240825_Gen_US
dc.subjectImmune-suppressionen_US
dc.subjectMortalityen_US
dc.subjectPeritoneal tuberculosisen_US
dc.subjectTreatmenten_US
dc.subjectTuberculosisen_US
dc.subjectisoniaziden_US
dc.subjecttuberculostatic agenten_US
dc.subjectadulten_US
dc.subjectcomplicationen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectHuman immunodeficiency virus infectionen_US
dc.subjectliver cirrhosisen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectretrospective studyen_US
dc.subjecttuberculosisen_US
dc.subjectyoung adulten_US
dc.subjectAdulten_US
dc.subjectAntitubercular Agentsen_US
dc.subjectFemaleen_US
dc.subjectHIV Infectionsen_US
dc.subjectHumansen_US
dc.subjectIsoniaziden_US
dc.subjectLiver Cirrhosisen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectRetrospective Studiesen_US
dc.subjectTuberculosisen_US
dc.subjectYoung Adulten_US
dc.titleClinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI studyen_US
dc.typeArticleen_US

Dosyalar